Clinical Trial Update: Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tesmilifene in combination with docetaxel for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Tesmilifene (tesmilifene)

Snippet

Sponsor: YM BioSciences | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED